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and dedicated positioning equipment and evaluating 
MRI derived synthetic CT (sCT) of the pelvis region for PET 
AC and dose calculation to enable a PET/MRI-only setup. 
Materials and Methods: Nine patients underwent PET/
MRI (Siemens Biograph mMR) scan in RT position. Each 
patient had a CT available and one patient was referred for 
RT. The PET/MRI scan protocol included multiparametric 
imaging with a total scan time of 35 minutes. The PET signal 
attenuation and CT-based attenuation correction of the 
dedicated RT setup including a flat table overlay, leg fixation 
device, flexible surface coil, and coil holders were evaluated 
using both phantom and clinical measurements.A deep 
convolutional neural network was trained to generate 
sCT from the corresponding Dixon MRI by including also 
data of sixteen patients from another ongoing study. 
For one patient the sCT was evaluated by measuring the 
mean absolute difference between the dose distributions 
calculated on sCT and CT. PET images reconstructed with 
sCT and co-registered CT were compared by the voxel-wise 
relative difference. Results: Phantom imaging with the RT 
flat table overlay revealed 2.3% reduction in total prompt. 
The PET photon attenuation for the phantom was up to 
14.6% near to the table, which was reduced to 0.5%±3.2% 
using the generated hardware AC map. Comparable 
results were found in the patient study resulting in a 
16% underestimation of SUVmean without AC of the RT 
equipment.AI based sCT was inferred for each patient in 
less than 5 seconds. There was an excellent voxel-by-voxel 
correlation between CT and sCT (P <0.01). The dosimetric 
analysis of the sCT-based dose planning showed a mean 
absolute error (MAE) of 0.12 Gy within the body contour and 
0.18 Gy inside the planning target volume (PTV). PET image 
reconstructed with sCT compared to the one reconstructed 
with CT had relative differences of 6.2%±1.7% within 
the tumor. Conclusion: These preliminary results suggest 
that multiparametric PET/MRI-only can be successfully 
integrated in the radiotherapy workflow of patients with 
cervical cancer. Patient recruitment is ongoing for validation 
of the robustness of the setup. References: None
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Aim/Introduction: To assess the usefulness of sentinel lymph 
node biopsy (SLNB) technique in patients with breast 
cancer after neoadjuvant chemotherapy (NAC). Materials 
and Methods: Retrospective series of 80 women with breast 
cancer who underwent a lymphoscintigraphy after the 
periareolar/peritumoral injection of 111MBq of 99mTc-
nanocoloid for the detection of the sentinel lymph node 
post-NAC between June 2016 and April 2020. Variables 
such as age, carcinoma histology, molecular subtype, BRCA 
gene mutations, focality, axillary staging pre-NAC (clinical, 
US/MRI, FNA), tumor size, type of surgery, radiological 
response, lymphoscintigraphy result and intraoperative 
SLNB result (by using OSNA method) were analyzed. 
Results: Average age was 50 years (48% between 45-60 
years). The main histological type was invasive ductal 
carcinoma (75), followed by infiltrating lobular carcinoma 
(4) and metaplastic (1). Regarding tumor characteristics 
we found that: 29 patients were triple-negative (36%), 19 
luminal B-HER2, 13 HER2neu, 16 luminal B and 3 luminal 
A. BRCA1 gene mutations were detected in 3 patients. 
1 tumor was multifocal and 7 multicenter. Axillary 
involvement pre-NAC was observed in 40 patients (50%): 
4 clinically+ and US/MRI/FNA-, 7 US/MRI+ and FNA-, and 
29 with axillary FNA+. 33 of them (83%) showed a tumor 
size <5cm (T1-T2) and the remaining 7 >5cm (T3-T4). 
Conservative surgery (lumpectomy/quadrantectomy) was 
performed in 54 patients (68%). 54% showed complete 
radiological response. Lymphoscintigraphy detected the 
SLN in 76 patients (95%). 4 were not detected despite 
reinjection, so an axillary lymph node dissection (ALND) 
was performed (3 without lymphatic invasion and 1 with 
5/9 macrometastases). When evaluating SLNB result, it was 
observed to be: 1. Negative in 61 patients: -Axillary lymph-
node preservation in 42 (69%): 1 metaplastic carcinoma. 17 
triple-negative (1 of them synchronous bilateral carcinoma), 
5 HER2neu (1 showed partial radiological response) and 8 
luminal B-HER2. 1 multifocal and 4 multicenter. 8 patients 
with axillary affectation pre-NAC (1 clinically, 1 US/MRI+ 
and 6 FNA+) and 34 with negative axillary lymph nodes. 
9 patients operated with a mastectomy. -ALND was 
performed in 19: they showed partial radiological response 
and/or suspicious lymph nodes intraoperatively (14 with 
lymphatic invasion pre-NAC). However, 73% without 
metastases. 2. Positive in 15 patients: -Axillary lymph-node 
preservation in 3 (20%) with micrometastases. -ALND in 12 
with macrometastases: 9 showed axillary involvement pre-
NAC. Conclusion: SLNB is a very useful technique in patients 
with NAC by avoiding a high number of unnecessary axillary 
lymphadenectomies, even in those with a worse prognosis, 
improving their quality of life. References: None
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Aim/Introduction: To analyze how many of the patients 
undergoing neoadjuvant chemotherapy (NCT) may benefit 
from SLNB, as well as the impact on patient management, 
especially in those with early axillary involvement. Materials 
and Methods: We included patients with breast carcinoma 
candidates to NCT discussed at the Tumor Committee 
of our hospital (April/2017-August/2019). All of them 
were subjected to clinical assessment, ultrasound and, if 
appropriate, histological analysis, axillary pre and post-
NCT. Sentinel lymph node detection was performed after 
periareolar injection of [99mTc]Tc-nanocoloid (74 MBq) the 
day before surgery. In some cases, blue dye was injected 
and/or a pre-NPC metal clip was placed in the affected 
node. Results: Sixty-two patients were included. NCT 
achieved a complete breast response in 12 patients, partial 
in 46 and non-response in 4. Initially, 31 patients were 
classified as N0 and 31 as N+ (28 N1 and 3 N2), achieving 
a complete axillary response in 58% of N+ (18). SLNB was 
performed in 49 patients (79%; 100% in N0 and 58% in N+ 
from baseline). The gamma detection rate of the sentinel 
lymph node was 91.8% (93.5% in N0 and 88.9% in N+). 28 
lymphadenectomies were undergone (45.2%; 22.5% in 
N0 and 67.7% in N+), 11 due to positive SLNB (5 N0 and 
6 N1), 13 owing to lack of axillary response and 4 caused 
by the non-localization of the sentinel lymph node. SLNB 
was performed in 58% of N+ patients, of which 44.4% 
were negative, avoiding lymphadenectomy. Metal clip 
and/or blue dye techniques were used in 31 cases (50%). 
Conclusion: SLNB is viable in a high percentage of patients 
with previous NCT, with a high detection rate, even in patients 
with early affected axilla, avoiding lymphadenectomy to 
patients who achieve a complete response of the axillary 
lymph node. References: None
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Aim/Introduction: To assess the probability of tumor 
recurrence at 5 years in patients with personal history of 
breast cancer in whom sentinel lymph node biopsy (SLNB) 
was performed. Materials and Methods: Retrospective 
series of 123 patients with breast cancer who underwent 
lymphoscintigraphy to detect the SLN and subsequent 
intraoperative exeresis between January 2014 and 
December 2014. Variables such as age, sex, SLNB result, 
tumor recurrence at 5 years and exitus until January 2020 
were analyzed. Data were also collected from patients 
with disease recurrence: age, sex, histology and tumor size, 
if triple-negative (negative estrogen and progesterone 
receptors and also negative HER2), percentage of nuclei 
with positive staining in tumor cells (Ki-67 score), SLNB 
result and location of recurrence. Results: 122 women and 
1 man with average age of 55 years were studied. SLNB was 
negative in 76 patients (62%). Recurrence was detected in 
6 patients, all of them women with mean age of 60 years. 
Regarding tumor characteristics in this group: histological 
types found were invasive ductal carcinoma (IDC) in 5 
patients and carcinosarcoma in 1, and an average size of 
20mm. 33% of them were triple-negative and showed Ki-
67 percentage score of 70-80%. When evaluating SLNB 
result, it was observed to be: 1. Negative in 2 of the relapsed 
patients: 1 showed distant recurrence at 3 years in the liver, 
and 1 presented new lesion in the contralateral breast at 2 
years (second SLNB also negative). 2. Positive in 4 patients, 
with axillary lymph node dissection (ALND) performed: 
2 showed local recurrence (surgical site) and 2 presented 
distant disease (1 in the liver and 1 had a mass with superior 
vena cava thrombosis). Therefore, the recurrence of disease 
at 5 years is 5% in our sample (6/123): 33% (2/6) with previous 
negative sentinel lymph node biopsy; 66% (4/6) with 
positive SLNB and ALND. Until January 2020, 6 of the 123 
patients deceased, but just 3 due to recurrence. Conclusion: 
The recurrence of the disease at 5 years is not relevant in 
patients undergoing sentinel lymph node biopsy. However, 
there is a higher incidence in those who showed positive 
SLNB and ALND was performed, probably due to some 
prognostic factors such as tumour size, histology, hormone 
receptors expression, or Ki-67 score. References: None
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